nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—head and neck cancer	0.832	1	CbGaD
Triamcinolone—Nasal irritation—Fluorouracil—head and neck cancer	0.00802	0.0479	CcSEcCtD
Triamcinolone—Skin atrophy—Hydroxyurea—head and neck cancer	0.0064	0.0382	CcSEcCtD
Triamcinolone—Atrophy—Hydroxyurea—head and neck cancer	0.00593	0.0354	CcSEcCtD
Triamcinolone—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.00519	0.031	CcSEcCtD
Triamcinolone—Nasal discomfort—Fluorouracil—head and neck cancer	0.00487	0.0291	CcSEcCtD
Triamcinolone—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.00398	0.0238	CcSEcCtD
Triamcinolone—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00349	0.0208	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00325	0.0194	CcSEcCtD
Triamcinolone—Peptic ulcer—Vinblastine—head and neck cancer	0.00317	0.0189	CcSEcCtD
Triamcinolone—Application site reaction—Fluorouracil—head and neck cancer	0.00297	0.0177	CcSEcCtD
Triamcinolone—Neuritis—Vinblastine—head and neck cancer	0.00284	0.0169	CcSEcCtD
Triamcinolone—Lupus erythematosus—Docetaxel—head and neck cancer	0.0027	0.0161	CcSEcCtD
Triamcinolone—Blister—Hydroxyurea—head and neck cancer	0.00268	0.016	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00234	0.014	CcSEcCtD
Triamcinolone—Ulcer—Hydroxyurea—head and neck cancer	0.00204	0.0122	CcSEcCtD
Triamcinolone—Blister—Fluorouracil—head and neck cancer	0.00193	0.0115	CcSEcCtD
Triamcinolone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00184	0.011	CcSEcCtD
Triamcinolone—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00181	0.0108	CcSEcCtD
Triamcinolone—Menstruation irregular—Docetaxel—head and neck cancer	0.00181	0.0108	CcSEcCtD
Triamcinolone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00172	0.0103	CcSEcCtD
Triamcinolone—Stinging—Fluorouracil—head and neck cancer	0.00172	0.0103	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00169	0.0101	CcSEcCtD
Triamcinolone—Embolism—Docetaxel—head and neck cancer	0.00156	0.00934	CcSEcCtD
Triamcinolone—Ulcer—Fluorouracil—head and neck cancer	0.00147	0.00878	CcSEcCtD
Triamcinolone—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00147	0.00876	CcSEcCtD
Triamcinolone—Throat sore—Docetaxel—head and neck cancer	0.00139	0.00832	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00138	0.00824	CcSEcCtD
Triamcinolone—Dermatitis contact—Fluorouracil—head and neck cancer	0.00137	0.00821	CcSEcCtD
Triamcinolone—Dermatitis atopic—Docetaxel—head and neck cancer	0.00136	0.0081	CcSEcCtD
Triamcinolone—Neuritis—Docetaxel—head and neck cancer	0.00134	0.00803	CcSEcCtD
Triamcinolone—Euphoric mood—Fluorouracil—head and neck cancer	0.0012	0.00714	CcSEcCtD
Triamcinolone—Pancreatitis—Hydroxyurea—head and neck cancer	0.00119	0.0071	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00117	0.00698	CcSEcCtD
Triamcinolone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00117	0.00696	CcSEcCtD
Triamcinolone—Myocardial infarction—Vinblastine—head and neck cancer	0.00116	0.00694	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00116	0.00694	CcSEcCtD
Triamcinolone—Oropharyngeal pain—Docetaxel—head and neck cancer	0.0011	0.00659	CcSEcCtD
Triamcinolone—Weight increased—Hydroxyurea—head and neck cancer	0.0011	0.00659	CcSEcCtD
Triamcinolone—Haemoglobin—Vinblastine—head and neck cancer	0.00107	0.00639	CcSEcCtD
Triamcinolone—Haemorrhage—Vinblastine—head and neck cancer	0.00106	0.00635	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00106	0.00633	CcSEcCtD
Triamcinolone—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00106	0.00631	CcSEcCtD
Triamcinolone—Pharyngitis—Vinblastine—head and neck cancer	0.00106	0.00631	CcSEcCtD
Triamcinolone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00101	0.00603	CcSEcCtD
Triamcinolone—Haemoglobin—Hydroxyurea—head and neck cancer	0.000975	0.00582	CcSEcCtD
Triamcinolone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00097	0.00579	CcSEcCtD
Triamcinolone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00096	0.00573	CcSEcCtD
Triamcinolone—Skin exfoliation—Docetaxel—head and neck cancer	0.000959	0.00572	CcSEcCtD
Triamcinolone—Candida infection—Docetaxel—head and neck cancer	0.000959	0.00572	CcSEcCtD
Triamcinolone—Fluid retention—Docetaxel—head and neck cancer	0.000953	0.00569	CcSEcCtD
Triamcinolone—Neuropathy—Docetaxel—head and neck cancer	0.000943	0.00563	CcSEcCtD
Triamcinolone—Pulmonary oedema—Docetaxel—head and neck cancer	0.000894	0.00534	CcSEcCtD
Triamcinolone—Muscular weakness—Fluorouracil—head and neck cancer	0.000891	0.00532	CcSEcCtD
Triamcinolone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00086	0.00513	CcSEcCtD
Triamcinolone—Erythema—Hydroxyurea—head and neck cancer	0.000845	0.00504	CcSEcCtD
Triamcinolone—Thrombophlebitis—Docetaxel—head and neck cancer	0.000842	0.00503	CcSEcCtD
Triamcinolone—Malaise—Vinblastine—head and neck cancer	0.000835	0.00499	CcSEcCtD
Triamcinolone—Vertigo—Vinblastine—head and neck cancer	0.000832	0.00497	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000811	0.00484	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000804	0.0048	CcSEcCtD
Triamcinolone—Convulsion—Vinblastine—head and neck cancer	0.000803	0.00479	CcSEcCtD
Triamcinolone—Hypertension—Vinblastine—head and neck cancer	0.0008	0.00478	CcSEcCtD
Triamcinolone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000784	0.00468	CcSEcCtD
Triamcinolone—Discomfort—Vinblastine—head and neck cancer	0.000779	0.00465	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000767	0.00458	CcSEcCtD
Triamcinolone—Myocardial infarction—Fluorouracil—head and neck cancer	0.000763	0.00455	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000763	0.00455	CcSEcCtD
Triamcinolone—Dermatitis bullous—Docetaxel—head and neck cancer	0.000763	0.00455	CcSEcCtD
Triamcinolone—Malaise—Hydroxyurea—head and neck cancer	0.000762	0.00455	CcSEcCtD
Triamcinolone—Conjunctivitis—Fluorouracil—head and neck cancer	0.000756	0.00452	CcSEcCtD
Triamcinolone—Epistaxis—Fluorouracil—head and neck cancer	0.000734	0.00438	CcSEcCtD
Triamcinolone—Convulsion—Hydroxyurea—head and neck cancer	0.000732	0.00437	CcSEcCtD
Triamcinolone—Discomfort—Hydroxyurea—head and neck cancer	0.000711	0.00424	CcSEcCtD
Triamcinolone—Haemoglobin—Fluorouracil—head and neck cancer	0.000702	0.00419	CcSEcCtD
Triamcinolone—Rhinitis—Fluorouracil—head and neck cancer	0.0007	0.00418	CcSEcCtD
Triamcinolone—Haemorrhage—Fluorouracil—head and neck cancer	0.000699	0.00417	CcSEcCtD
Triamcinolone—Pharyngitis—Fluorouracil—head and neck cancer	0.000693	0.00414	CcSEcCtD
Triamcinolone—Oedema—Hydroxyurea—head and neck cancer	0.000689	0.00412	CcSEcCtD
Triamcinolone—Infection—Hydroxyurea—head and neck cancer	0.000685	0.00409	CcSEcCtD
Triamcinolone—Paraesthesia—Vinblastine—head and neck cancer	0.000679	0.00405	CcSEcCtD
Triamcinolone—Pain—Vinblastine—head and neck cancer	0.000647	0.00386	CcSEcCtD
Triamcinolone—Arrhythmia—Fluorouracil—head and neck cancer	0.000624	0.00373	CcSEcCtD
Triamcinolone—Feeling abnormal—Vinblastine—head and neck cancer	0.000623	0.00372	CcSEcCtD
Triamcinolone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000615	0.00367	CcSEcCtD
Triamcinolone—Erythema—Fluorouracil—head and neck cancer	0.000608	0.00363	CcSEcCtD
Triamcinolone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000607	0.00362	CcSEcCtD
Triamcinolone—Fatigue—Hydroxyurea—head and neck cancer	0.000594	0.00355	CcSEcCtD
Triamcinolone—Pain—Hydroxyurea—head and neck cancer	0.00059	0.00352	CcSEcCtD
Triamcinolone—Weight increased—Docetaxel—head and neck cancer	0.000573	0.00342	CcSEcCtD
Triamcinolone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000568	0.00339	CcSEcCtD
Triamcinolone—Hypersensitivity—Vinblastine—head and neck cancer	0.000557	0.00333	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000554	0.00331	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000551	0.00329	CcSEcCtD
Triamcinolone—Myocardial infarction—Docetaxel—head and neck cancer	0.000551	0.00329	CcSEcCtD
Triamcinolone—Conjunctivitis—Docetaxel—head and neck cancer	0.000546	0.00326	CcSEcCtD
Triamcinolone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000545	0.00325	CcSEcCtD
Triamcinolone—Asthenia—Vinblastine—head and neck cancer	0.000542	0.00324	CcSEcCtD
Triamcinolone—Epistaxis—Docetaxel—head and neck cancer	0.00053	0.00316	CcSEcCtD
Triamcinolone—Convulsion—Fluorouracil—head and neck cancer	0.000527	0.00315	CcSEcCtD
Triamcinolone—Myalgia—Fluorouracil—head and neck cancer	0.000518	0.00309	CcSEcCtD
Triamcinolone—Discomfort—Fluorouracil—head and neck cancer	0.000511	0.00305	CcSEcCtD
Triamcinolone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000508	0.00303	CcSEcCtD
Triamcinolone—Haemoglobin—Docetaxel—head and neck cancer	0.000507	0.00303	CcSEcCtD
Triamcinolone—Rhinitis—Docetaxel—head and neck cancer	0.000505	0.00302	CcSEcCtD
Triamcinolone—Haemorrhage—Docetaxel—head and neck cancer	0.000504	0.00301	CcSEcCtD
Triamcinolone—Pharyngitis—Docetaxel—head and neck cancer	0.0005	0.00299	CcSEcCtD
Triamcinolone—Dizziness—Vinblastine—head and neck cancer	0.0005	0.00299	CcSEcCtD
Triamcinolone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000496	0.00296	CcSEcCtD
Triamcinolone—Oedema—Fluorouracil—head and neck cancer	0.000496	0.00296	CcSEcCtD
Triamcinolone—Asthenia—Hydroxyurea—head and neck cancer	0.000495	0.00295	CcSEcCtD
Triamcinolone—Infection—Fluorouracil—head and neck cancer	0.000493	0.00294	CcSEcCtD
Triamcinolone—Tachycardia—Fluorouracil—head and neck cancer	0.000484	0.00289	CcSEcCtD
Triamcinolone—Vomiting—Vinblastine—head and neck cancer	0.000481	0.00287	CcSEcCtD
Triamcinolone—Headache—Vinblastine—head and neck cancer	0.000474	0.00283	CcSEcCtD
Triamcinolone—Dizziness—Hydroxyurea—head and neck cancer	0.000456	0.00272	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000452	0.0027	CcSEcCtD
Triamcinolone—Arrhythmia—Docetaxel—head and neck cancer	0.00045	0.00269	CcSEcCtD
Triamcinolone—Nausea—Vinblastine—head and neck cancer	0.000449	0.00268	CcSEcCtD
Triamcinolone—Insomnia—Fluorouracil—head and neck cancer	0.000449	0.00268	CcSEcCtD
Triamcinolone—Paraesthesia—Fluorouracil—head and neck cancer	0.000446	0.00266	CcSEcCtD
Triamcinolone—Dyspnoea—Fluorouracil—head and neck cancer	0.000442	0.00264	CcSEcCtD
Triamcinolone—Erythema—Docetaxel—head and neck cancer	0.000439	0.00262	CcSEcCtD
Triamcinolone—Vomiting—Hydroxyurea—head and neck cancer	0.000438	0.00262	CcSEcCtD
Triamcinolone—Dyspepsia—Fluorouracil—head and neck cancer	0.000437	0.00261	CcSEcCtD
Triamcinolone—Rash—Hydroxyurea—head and neck cancer	0.000435	0.0026	CcSEcCtD
Triamcinolone—Dermatitis—Hydroxyurea—head and neck cancer	0.000434	0.00259	CcSEcCtD
Triamcinolone—Headache—Hydroxyurea—head and neck cancer	0.000432	0.00258	CcSEcCtD
Triamcinolone—Clobetasol propionate—CYP1A1—head and neck cancer	0.00043	0.497	CrCbGaD
Triamcinolone—Dysgeusia—Docetaxel—head and neck cancer	0.00043	0.00257	CcSEcCtD
Triamcinolone—Back pain—Docetaxel—head and neck cancer	0.000425	0.00253	CcSEcCtD
Triamcinolone—Pain—Fluorouracil—head and neck cancer	0.000424	0.00253	CcSEcCtD
Triamcinolone—Nausea—Hydroxyurea—head and neck cancer	0.00041	0.00245	CcSEcCtD
Triamcinolone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000409	0.00244	CcSEcCtD
Triamcinolone—Urticaria—Fluorouracil—head and neck cancer	0.000394	0.00235	CcSEcCtD
Triamcinolone—Syncope—Docetaxel—head and neck cancer	0.000394	0.00235	CcSEcCtD
Triamcinolone—Body temperature increased—Fluorouracil—head and neck cancer	0.000392	0.00234	CcSEcCtD
Triamcinolone—Loss of consciousness—Docetaxel—head and neck cancer	0.000386	0.0023	CcSEcCtD
Triamcinolone—Cough—Docetaxel—head and neck cancer	0.000383	0.00229	CcSEcCtD
Triamcinolone—Convulsion—Docetaxel—head and neck cancer	0.00038	0.00227	CcSEcCtD
Triamcinolone—Hypertension—Docetaxel—head and neck cancer	0.000379	0.00226	CcSEcCtD
Triamcinolone—Myalgia—Docetaxel—head and neck cancer	0.000374	0.00223	CcSEcCtD
Triamcinolone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000366	0.00218	CcSEcCtD
Triamcinolone—Dry mouth—Docetaxel—head and neck cancer	0.000365	0.00218	CcSEcCtD
Triamcinolone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000358	0.00214	CcSEcCtD
Triamcinolone—Oedema—Docetaxel—head and neck cancer	0.000358	0.00214	CcSEcCtD
Triamcinolone—Infection—Docetaxel—head and neck cancer	0.000356	0.00212	CcSEcCtD
Triamcinolone—Shock—Docetaxel—head and neck cancer	0.000352	0.0021	CcSEcCtD
Triamcinolone—Pruritus—Fluorouracil—head and neck cancer	0.000351	0.0021	CcSEcCtD
Triamcinolone—Tachycardia—Docetaxel—head and neck cancer	0.00035	0.00209	CcSEcCtD
Triamcinolone—Dizziness—Fluorouracil—head and neck cancer	0.000328	0.00196	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000326	0.00195	CcSEcCtD
Triamcinolone—Insomnia—Docetaxel—head and neck cancer	0.000324	0.00193	CcSEcCtD
Triamcinolone—Paraesthesia—Docetaxel—head and neck cancer	0.000322	0.00192	CcSEcCtD
Triamcinolone—Dyspnoea—Docetaxel—head and neck cancer	0.000319	0.00191	CcSEcCtD
Triamcinolone—Vomiting—Fluorouracil—head and neck cancer	0.000316	0.00188	CcSEcCtD
Triamcinolone—Dyspepsia—Docetaxel—head and neck cancer	0.000315	0.00188	CcSEcCtD
Triamcinolone—Rash—Fluorouracil—head and neck cancer	0.000313	0.00187	CcSEcCtD
Triamcinolone—Dermatitis—Fluorouracil—head and neck cancer	0.000313	0.00187	CcSEcCtD
Triamcinolone—Headache—Fluorouracil—head and neck cancer	0.000311	0.00186	CcSEcCtD
Triamcinolone—Fatigue—Docetaxel—head and neck cancer	0.000309	0.00184	CcSEcCtD
Triamcinolone—Pain—Docetaxel—head and neck cancer	0.000306	0.00183	CcSEcCtD
Triamcinolone—Feeling abnormal—Docetaxel—head and neck cancer	0.000295	0.00176	CcSEcCtD
Triamcinolone—Nausea—Fluorouracil—head and neck cancer	0.000295	0.00176	CcSEcCtD
Triamcinolone—Body temperature increased—Docetaxel—head and neck cancer	0.000283	0.00169	CcSEcCtD
Triamcinolone—Hypersensitivity—Docetaxel—head and neck cancer	0.000264	0.00158	CcSEcCtD
Triamcinolone—Asthenia—Docetaxel—head and neck cancer	0.000257	0.00153	CcSEcCtD
Triamcinolone—Pruritus—Docetaxel—head and neck cancer	0.000253	0.00151	CcSEcCtD
Triamcinolone—Dizziness—Docetaxel—head and neck cancer	0.000237	0.00141	CcSEcCtD
Triamcinolone—Vomiting—Docetaxel—head and neck cancer	0.000228	0.00136	CcSEcCtD
Triamcinolone—Rash—Docetaxel—head and neck cancer	0.000226	0.00135	CcSEcCtD
Triamcinolone—Dermatitis—Docetaxel—head and neck cancer	0.000226	0.00135	CcSEcCtD
Triamcinolone—Headache—Docetaxel—head and neck cancer	0.000224	0.00134	CcSEcCtD
Triamcinolone—Nausea—Docetaxel—head and neck cancer	0.000213	0.00127	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—head and neck cancer	0.000173	0.2	CrCbGaD
Triamcinolone—Dexamethasone—CYP1A1—head and neck cancer	0.000161	0.186	CrCbGaD
Triamcinolone—Dexamethasone—PTGS2—head and neck cancer	0.000101	0.116	CrCbGaD
